Publication | Open Access
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial
454
Citations
11
References
2019
Year
Surgical OncologyOncologyMedicineRandomised Phase 3PathologyPharmacotherapyPexidartinib Versus PlaceboAnti-cancer AgentCancer TreatmentPharmacologyRadiation OncologyCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1